Immune response to ovarian cancer may predict survival, Mayo-led study findsOctober 12, 2017
ROCHESTER, Minn. - A group of international cancer researchers led by investigators from Mayo Clinic and University of New South Wales Sydney has found that the level of a type of white blood cell, called tumor-infiltrating lymphocytes, present in the tumors of patients with high-grade ovarian cancer may predict a patient's survival. Results of the study by the Ovarian Tumor Tissue Analysis Consortium were published today in JAMA Oncology.
"We know that a type of tumor-infiltrating lymphocyte called cytotoxic CD8 are present in the tumors of patients with high-grade ovarian cancer," says Matthew Block, M.D., Ph.D., a Mayo Clinic oncologist who co-led the research team with Ellen Goode, Ph.D., of the Mayo Clinic Cancer Center Genetic Epidemiology and Risk Assessment Program. "However, little was known about the role in fighting high-grade ovarian cancer, compared to other clinical factors."
To help answer this question, researchers studied more than 5,500 patients from nine different countries, including 3,196 with high-grade ovarian cancer. Researchers found that patients with high-grade ovarian cancer showed the most infiltration with tumor-infiltrating lymphocytes, which were associated with longer overall survival.
"This study shows the higher the level of cytotoxic CD8 tumor-infiltrating lymphocytes in a tumor, the better the survival for patients with high-grade ovarian cancer," says Dr. Block. "Developing a better understanding of factors that increase cytotoxic CD8 tumor-infiltrating lymphocytes will be the key to developing treatments to achieve better outcomes in treating patients with high-grade ovarian cancer.
"This is by far the largest study of this type and would not have been possible without scientists from North and South America, Europe and Australia all working together," says Susan Ramus, Ph.D., University of New South Wales Sydney.
As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call the Clinical Trial Referral Office at 1-855-776-0015 (toll-free).
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, comprehensive care to everyone who needs healing. For more information, visit mayoclinic.org/about-mayo-clinic or newsnetwork.mayoclinic.org.
Related Tumors Articles:
An analysis of breast cancer data revealed that many small breast cancers have an excellent prognosis because they are inherently slow growing, according to Yale Cancer Center experts.
An IDIBELL research team manages to characterize the complete epigenomes of the most frequent tumors, including those of colon, lung and breast cancer.
Rakesh Jain, Ph.D., Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and supported by the National Foundation for Cancer Research, has discovered a novel mechanism behind the resistance to HER2- or PI3K-targeted therapies, and a treatment strategy that may overcome treatment resistance.
MIT engineers have developed a highly sensitive way to reveal ovarian tumors: In tests in mice, they were able to detect tumors smaller than 2 millimeters in diameter.
Dr. Amanda Paulovich, whose lab has a leading role in the Beau Biden Cancer Moonshot, will speak April 5 at the AACR annual meeting about her lab's pioneering methods to measure proteins that serve as tumor markers.
A new research analysis provides physicians and patients with new information to help them make difficult decisions about how to treat tumors and infections.
A new active pharmaceutical ingredient may help against severe forms of testicular cancer, which only respond inadequately to other therapies.
Immunotherapy is a new and highly promising form of treatment for cancer, but in many patients, tumors recur.
Scientists of Helmholtz Zentrum München and the Munich University Hospital (LMU) are developing a novel antibody to treat brain tumors.
A recent study reported in the May issue of the Journal of Nuclear Medicine demonstrates that Ga-68 DOTATATE PET/CT scans are superior to In-111 pentetreotide scans, the current imaging standard in the United States for detecting neuroendocrine tumors, and could significantly impact treatment management.
Related Tumors Reading:
Everybody Needs a Brain Tumor
by David Paul Koelliker (Author), John David Koelliker (Compiler)
Everybody Needs a Brain Tumor details the experience of David Koelliker's 8+ year battle with a brain tumor and the many lessons he's learned along the way. According to the American Brain Tumor Association, nearly 80,000 people will be diagnosed with a brain tumor this year. Roughly a third of those are malignant. Every day there are families being told that their mother, father, brother, sister, or child has 3-18 months to live. Your life's 'brain tumor' may be something else. It might be an addiction, a disability, cancer, or losing a close friend or family member. The purpose of this book... View Details
Tumor (Object Lessons)
by Anna Leahy (Author), Christopher Schaberg (Series Editor), Ian Bogost (Series Editor)
Object Lessons is a series of short, beautifully designed books about the hidden lives of ordinary things.
One in two men and one in three women will develop invasive cancer. Tumors have the power to redefine identities and change how people live with one another.
Tumor takes readers on an intellectual adventure around the attitudes that shape how humans do scientific research, treat cancer, and talk about disease, treatment, and death. With poetic verve and acuity, Anna Leahy explores why and how tumors happen, how we think and talk about them, and how we try to rid... View Details
Tumors in Domestic Animals
by Donald J. Meuten (Editor)
Tumors in Domestic Animals, Fifth Edition is a fully revised new edition of the most comprehensive and authoritative reference on veterinary tumor pathology in common domestic animals, now in full color throughout with the most current advances in research and diagnostics.Now in full color with hundreds of exquisite new images showing diagnostic features, pathogenesis, and techniques Adds new sections on relevant clinical pathology and oncology Updated throughout to include the very latest advances in research and diagnostics Takes a logical, user-friendly system approach... View Details
Navigating Life with a Brain Tumor (Neurology Now Books)
by Lynne P. Taylor (Author), Alyx B. Porter Umphrey (Author), Diane Richard (Contributor)
Providing readily accessible information and real-world encouragement to people living with primary and metastatic brain tumors, this book discusses the basics of brain tumors, types of tumors, management of different tumors, related symptoms, treatments and side effects, the role of medical team members, and coping strategies from initial diagnosis throughout the course of the illness. At the same time, it also offers practical suggestions on symptom management and lifestyle modification, as well as real-life anecdotes and advice from both patients and family members and friends who are... View Details
by Joshua Hale Fialkov (Author), Stephen Christy (Editor)
Introduction by Duane Swierczynski From the Harvey Award-nominated creative team of Elk's Run comes Tumor, the critically acclaimed sensation that was the first graphic novel to debut exclusively on the Kindle E-Book Reader! Tumor is the story of Frank Armstrong, a man at the boot heel of the world, barely scraping up a living as a private investigator in modern day Los Angeles. He finally lands a big case, finding the missing daughter of a drug kingpin, just as he's taken by the symptoms of a late-stage brain tumor. Memories blend with reality, as the missing girl case starts to seep into... View Details
Enzinger and Weiss's Soft Tissue Tumors: Expert Consult: Online and Print, 6e
by John R. Goldblum MD FCAP FASCP FACG (Author), Sharon W. Weiss MD (Author), Andrew L. Folpe MD (Author)
Enzinger and Weiss's Soft Tissue Tumors is your essential medical reference on the diagnosis of tumors of the skeletal muscles, connective tissue, fat, and related structures. No other source matches Enzinger and Weiss’s scope and depth of coverage in this complex and challenging area of surgical pathology, and no other text contains as much practical information on differential diagnosis. Microscopic findings are correlated with the latest developments in molecular biology, cytogenetics, and immunohistochemistry, providing you with a comprehensive... View Details
Cancer is a Fungus: A Revolution in Tumor Therapy
by Dr. T. Simoncini (Author)
Book describes how a fungous infection always forms the basis of every neoplastic formation, and this formation tries to spread within the whole organism without stopping. At the moment the constant, uniform, and implacable growth of a tumor is in no way affected by current oncological treatments. A recovery rate for cancer that fluctuates at around 7% is mentioned in the classical books and treatises in spite of all the tricks and distortion of statistics. After making the necessary corrections, this amounts to virtually nil. The rest is propaganda for orthodox oncology. On the basis of the... View Details
Blessed with a Brain Tumor: Realizing It's All Gift and Learning to Receive
by Pye Will (Author)
How can a brain tumor diagnosis be a gift? And how can a book about this experience be full of joy ... and have the potential to change your life? After a decade exploring the nature of reality and researching and experimenting with human potential Will Pye experienced an initiation at the age of thirty-one via a Grand Mal seizure and the subsequent diagnosis of a golf-ball-sized brain tumor. Will shares how he was able to experience the development with no stress or suffering, how the diagnosis became an opportunity for profound growth and how we too can access the gifts of such a wake-up... View Details
When Tumor Is the Rumor and Cancer Is the Answer: A Comprehensive Text for Newly Diagnosed Cancer Patients and their Families
by Kevin P. Ryan (Author)
The odds are more than forty percent that cancer will touch your life. Including families, cancer affects almost four million people per year. There are few common medical realities surrounded by as much malefaction, mystique, and misunderstanding as cancer. In When Tumor Is the Rumor and Cancer Is the Answer, author Dr. Kevin P. Ryan helps you see past the macabre mythology. Stressing patient autonomy and the need to build an Oncology team, Dr. Ryan addresses the need for knowledge when receiving the overwhelming news that you may or do have cancer. He covers not just the fear of the... View Details
Brain Tumor Guide For The Newly Diagnosed
by Al Musella DPM (Author)
Brain Tumor Guide for the Newly Diagnosed Version 9 is a comprehensive resource provided by the Musella Foundation For Brain Tumor Research & Information. The purpose of this guide is to provide you with tools, resources and ideas to explore further with your doctors and is not meant to be medical advice. An easy to read manual for those newly diagnosed with a brain tumor including sections on "Why Me?", tools to help you get organized, the role of caregivers and support groups, frequently asked questions, sex and fertility, and the latest information on treatments and clinical trials. If you... View Details